Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

EARNINGS UPDATES: Live Co achieves surge in interim revenue

30th Sep 2022 14:46

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

DG Innovate PLC - Bingley-England based storage battery manufacturer - Says grant income in the six months ended on June 30 falls to GBP344,831, from GBP675,816 a year ago. Pretax loss widens to GBP6.2 million from just GBP201,156, as administrative expenses jump to GBP1.2 million from GBP777,670 a year ago. "The first half of 2022 was transformational for the company, as we completed the reverse takeover of DGI to become DG Innovate PLC", Chair Nick Tulloch says. Looking ahead, it seeks to commercialise a suite of electric mobility and storage tech.

----------

Live Co Group PLC - UK-based live events and entertainment company - Posts a surge in revenue to GBP2.6 million for the six months ended on June 30, from GBP622,000 a year ago, as pretax loss narrows to GBP1.4 million from GBP2.1 million. Cost of sales increase to GBP1.7 million from GBP1.4 million a year earlier. Looking ahead, says it remains "cautiously optimistic" for 2023, citing increased demand for live events.

----------

NetScientific PLC - London-based life sciences and sustainability technology investment firm - Reports a fall in revenue to GBP391,000 for the six months ended June 30, from GBP407,000 a year ago. Pretax loss widens to GBP1.7 million from GBP1.5 million. Selling and administrative costs amount to GBP1.4 million, up from GBP1.2 million ago, mainly due to "increased headcount in the subsidiaries and at head office, and increased spending in drives towards commercialisation and eventual liquidity events".

----------

TechFinancials Inc - invests in early-stage technology companies - Posts no revenue for the six months ended on June 30. Pretax loss widens to USD163,000 from USD92,000 a year ago as financing expenses swing to a loss of USD89,000 from a profit of USD41,000.

----------

Apollon Formularies PLC - London-based medical cannabis pharmaceutical firm - Posts revenue of GBP165,053 in the six months ended on June 30, compared to none a year ago. Pretax loss narrows to GBP212,436 from GBP1.7 million, despite administrative expenses rising to GBP535,889 from GBP335,425 a year ago. No finance costs have incurred this year, compared to GBP3,799 last year.

-----------

By Xindi Wei; [email protected]

Copyright 2022 Alliance News Limited. All Rights Reserved.

FTSE 100 Latest
Value8,139.83
Change60.97